Trial intelligence / Profile preview

Oxygen Therapy in COPD Substudy

NCT05052125Phase 4Terminated

Start
Dec 2021
Primary completion
Aug 2024
Modality
Inhalation Devices
Countries
1
01

Overview

A Phase 4 trial of oxygen in chronic obstructive pulmonary disease (COPD). Started Dec 2021; status: terminated.

02

Drugs

oxygen
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT05052125.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05052125.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call